Chronic fluoxetine treatment up‐regulates dopamine receptors in the mesolimbic forebrain of the rat

Ronald P Hammer, Jody E. Margulies, Allison B. Lynn, Linda S. Brady

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The mechanism of antidepressant function is still largely unknown. The authors examined the binding of [H] SCH 23390 and [3H] spiperone to dopantine D1‐ and D2‐like receptors, respectively, using quantitative in vitro receptor autoradiogra‐phy inforebrain sections front rats treated for 8 weeks with 5 mg/kg fluoxetine HCl or vehicle. Fluoxetine treatment significantly increased dopamine D1 receptor density in the nucleus accumbens and D2 density in the nucleus accumbens, olfactory tubercle and islands of Calleja region. Neither D1 nor D2 receptors were significantly affected in the striatum. The results are discussed in light of additional evidence that antidepressants alter mesolimbic dopamine function. Although fluoxetine (Prozac) selectively inhibits reuptake of serotonin, its indirect effects on mesolimbic dopamine systems might underlie its potent efficacy as an antidepressant. Depression 1:82–87 (1993). © 1993 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)82-87
Number of pages6
JournalDepression
Volume1
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Fluoxetine
Dopamine Receptors
Prosencephalon
Up-Regulation
Antidepressive Agents
Nucleus Accumbens
Dopamine
Islands of Calleja
Spiperone
Dopamine D1 Receptors
Autoradiography
Serotonin

Keywords

  • antidepressants
  • D
  • D
  • dopamine
  • nucleus accumbens
  • serotonin

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Chronic fluoxetine treatment up‐regulates dopamine receptors in the mesolimbic forebrain of the rat. / Hammer, Ronald P; Margulies, Jody E.; Lynn, Allison B.; Brady, Linda S.

In: Depression, Vol. 1, No. 2, 1993, p. 82-87.

Research output: Contribution to journalArticle

Hammer, Ronald P ; Margulies, Jody E. ; Lynn, Allison B. ; Brady, Linda S. / Chronic fluoxetine treatment up‐regulates dopamine receptors in the mesolimbic forebrain of the rat. In: Depression. 1993 ; Vol. 1, No. 2. pp. 82-87.
@article{e793351b61a34a41be0ef755d40c54ef,
title = "Chronic fluoxetine treatment up‐regulates dopamine receptors in the mesolimbic forebrain of the rat",
abstract = "The mechanism of antidepressant function is still largely unknown. The authors examined the binding of [H] SCH 23390 and [3H] spiperone to dopantine D1‐ and D2‐like receptors, respectively, using quantitative in vitro receptor autoradiogra‐phy inforebrain sections front rats treated for 8 weeks with 5 mg/kg fluoxetine HCl or vehicle. Fluoxetine treatment significantly increased dopamine D1 receptor density in the nucleus accumbens and D2 density in the nucleus accumbens, olfactory tubercle and islands of Calleja region. Neither D1 nor D2 receptors were significantly affected in the striatum. The results are discussed in light of additional evidence that antidepressants alter mesolimbic dopamine function. Although fluoxetine (Prozac) selectively inhibits reuptake of serotonin, its indirect effects on mesolimbic dopamine systems might underlie its potent efficacy as an antidepressant. Depression 1:82–87 (1993). {\circledC} 1993 Wiley‐Liss, Inc.",
keywords = "antidepressants, D, D, dopamine, nucleus accumbens, serotonin",
author = "Hammer, {Ronald P} and Margulies, {Jody E.} and Lynn, {Allison B.} and Brady, {Linda S.}",
year = "1993",
doi = "10.1002/depr.3050010204",
language = "English (US)",
volume = "1",
pages = "82--87",
journal = "Depression",
issn = "1062-6417",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Chronic fluoxetine treatment up‐regulates dopamine receptors in the mesolimbic forebrain of the rat

AU - Hammer, Ronald P

AU - Margulies, Jody E.

AU - Lynn, Allison B.

AU - Brady, Linda S.

PY - 1993

Y1 - 1993

N2 - The mechanism of antidepressant function is still largely unknown. The authors examined the binding of [H] SCH 23390 and [3H] spiperone to dopantine D1‐ and D2‐like receptors, respectively, using quantitative in vitro receptor autoradiogra‐phy inforebrain sections front rats treated for 8 weeks with 5 mg/kg fluoxetine HCl or vehicle. Fluoxetine treatment significantly increased dopamine D1 receptor density in the nucleus accumbens and D2 density in the nucleus accumbens, olfactory tubercle and islands of Calleja region. Neither D1 nor D2 receptors were significantly affected in the striatum. The results are discussed in light of additional evidence that antidepressants alter mesolimbic dopamine function. Although fluoxetine (Prozac) selectively inhibits reuptake of serotonin, its indirect effects on mesolimbic dopamine systems might underlie its potent efficacy as an antidepressant. Depression 1:82–87 (1993). © 1993 Wiley‐Liss, Inc.

AB - The mechanism of antidepressant function is still largely unknown. The authors examined the binding of [H] SCH 23390 and [3H] spiperone to dopantine D1‐ and D2‐like receptors, respectively, using quantitative in vitro receptor autoradiogra‐phy inforebrain sections front rats treated for 8 weeks with 5 mg/kg fluoxetine HCl or vehicle. Fluoxetine treatment significantly increased dopamine D1 receptor density in the nucleus accumbens and D2 density in the nucleus accumbens, olfactory tubercle and islands of Calleja region. Neither D1 nor D2 receptors were significantly affected in the striatum. The results are discussed in light of additional evidence that antidepressants alter mesolimbic dopamine function. Although fluoxetine (Prozac) selectively inhibits reuptake of serotonin, its indirect effects on mesolimbic dopamine systems might underlie its potent efficacy as an antidepressant. Depression 1:82–87 (1993). © 1993 Wiley‐Liss, Inc.

KW - antidepressants

KW - D

KW - D

KW - dopamine

KW - nucleus accumbens

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=85005307876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005307876&partnerID=8YFLogxK

U2 - 10.1002/depr.3050010204

DO - 10.1002/depr.3050010204

M3 - Article

AN - SCOPUS:85005307876

VL - 1

SP - 82

EP - 87

JO - Depression

JF - Depression

SN - 1062-6417

IS - 2

ER -